CPT® Code 80081

Obstetric panel (includes HIV testing) This panel must include the following: Blood count, complete (CBC), and automated differential WBC count (85025 or 85027 and 85004) OR Blood count, complete (CBC), automated (85027) and appropriate manual differential WBC count (85007 or 85009) Hepatitis B surface antigen (HBsAg) (87340) HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result (87389) Antibody, rubella (86762) Syphilis test, non-treponemal antibody; qualitative (eg, VDRL, RPR, ART) (86592) Antibody screen, RBC, each serum technique (86850) Blood typing, ABO (86900) AND Blood typing, Rh (D) (86901)

The CPT® Code 80081 refers to an obstetric panel that encompasses a series of laboratory tests performed on maternal blood, typically prior to or during pregnancy. This panel is essential for identifying and monitoring various medical conditions that could potentially impact the health of both the mother and the developing fetus. The tests included in this panel are designed to screen for infections, anemia, coagulopathy, and immune disorders, which are critical for ensuring a healthy pregnancy outcome. The panel specifically includes a complete blood count (CBC) with either an automated differential white blood cell (WBC) count or a manual differential WBC count. A CBC provides vital information about the blood's components, including hemoglobin (Hgb), hematocrit (Hct), red blood cell (RBC) count, WBC count, and platelet count. Hematocrit measures the proportion of blood volume occupied by red blood cells, while the RBC count indicates the number of erythrocytes present in a specified volume of blood. The WBC count reflects the number of white blood cells, which are crucial for the immune response, and includes five distinct types: neutrophils, eosinophils, basophils, monocytes, and lymphocytes, each counted separately in a differential analysis. The platelet count assesses the number of thrombocytes, which play a key role in blood clotting. In addition to the CBC, the obstetric panel mandates the inclusion of several specific tests: Hepatitis B surface antigen (HBsAg), which screens for Hepatitis B infection; human immunodeficiency virus-1 (HIV-1) antigen along with antibodies for both HIV-1 and HIV-2; rubella antibody testing; a qualitative syphilis test for non-treponemal antibodies (such as VDRL, RPR, or ART); an antibody screen for red blood cells; and blood typing for both ABO and Rh D factors. Collectively, these tests provide comprehensive insights into the maternal health status and help guide appropriate clinical management during pregnancy.